ArticleBMC neurology2026
Inferior olive lesions in autoimmune glial fibrillary acidic protein astrocytopathy: a report of two cases.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a newly identified inflammatory nervous system disorder characterized by Immunoglobulin G autoantibodies against GFAP. While several MRI features are considered typical for autoimmune GFAP astrocytopathy, reports of lesions affecting the inferior olivary nucleus (ION) are rare. In this context, we present two cases of autoimmune GFAP astrocytopathy with lesions in the ION. CASE PRESENTATION: Case 1 involved a 64-year-old man with meningoencephalomyelitis, peripheral neuropathy, and autonomic dysfunction. His brain MRI revealed bilateral ION lesions and changes along the dentato–rubro–olivary pathway, likely indicating hypertrophic olivary degeneration (HOD). Spinal cord MRI showed bilateral T2 hyperintensities in the anterior horns and a longitudinally extensive spinal cord lesion. In Case 2, a 60-year-old man presented with meningoradiculitis. Although he lacked encephalitic symptoms, his brain MRI showed a left ION lesion with radial perivascular enhancement in the periventricular white matter. The olivary lesion was not linked to other abnormalities along the dentato–rubro–olivary pathway, and contrast enhancement appeared in the same region before the T2 lesion was visible. These findings imply that the inferior olivary involvement in Case 2 was a primary inflammatory lesion. Palatal tremor was not observed in either case.
conclusionsIn autoimmune GFAP astrocytopathy, lesions in the ION can appear either as a primary inflammatory response or as HOD resulting from disruption of the dentato–rubro–olivary pathway. When ION lesions are detected during an acute phase that suggests inflammation, autoimmune GFAP astrocytopathy should be included in the differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.